These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
308 related items for PubMed ID: 30779066
1. MicroRNA-95-3p promoted the development of prostatic cancer via regulating DKK3 and activating Wnt/β-catenin pathway. Xi M, Cheng L, Hua W, Zhou YL, Gao QL, Yang JX, Qi SY. Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1002-1011. PubMed ID: 30779066 [Abstract] [Full Text] [Related]
3. Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway. Xiong L, Tang Y, Tang J, Liu Z, Wang X. Cancer Biother Radiopharm; 2020 Nov; 35(9):720-730. PubMed ID: 31910357 [Abstract] [Full Text] [Related]
4. miR-15a-3p Suppresses Prostate Cancer Cell Proliferation and Invasion by Targeting SLC39A7 Via Downregulating Wnt/β-Catenin Signaling Pathway. Cui Y, Yang Y, Ren L, Yang J, Wang B, Xing T, Chen H, Chen M. Cancer Biother Radiopharm; 2019 Sep; 34(7):472-479. PubMed ID: 31135177 [Abstract] [Full Text] [Related]
6. LncRNA NCK1-AS1 exerts oncogenic property in gastric cancer by targeting the miR-22-3p/BCL9 axis to activate the Wnt/β-catenin signaling. Guan B, Ma J, Yang Z, Yu F, Yao J. Environ Toxicol; 2021 Aug; 36(8):1640-1653. PubMed ID: 33974352 [Abstract] [Full Text] [Related]
9. MiR-19a-3p regulates the Forkhead box F2-mediated Wnt/β-catenin signaling pathway and affects the biological functions of colorectal cancer cells. Yu FB, Sheng J, Yu JM, Liu JH, Qin XX, Mou B. World J Gastroenterol; 2020 Feb 14; 26(6):627-644. PubMed ID: 32103872 [Abstract] [Full Text] [Related]
10. Epigenetic silencing of miR-490-3p promotes development of an aggressive colorectal cancer phenotype through activation of the Wnt/β-catenin signaling pathway. Zheng K, Zhou X, Yu J, Li Q, Wang H, Li M, Shao Z, Zhang F, Luo Y, Shen Z, Chen F, Shi F, Cui C, Zhao D, Lin Z, Zheng W, Zou Z, Huang Z, Zhao L. Cancer Lett; 2016 Jun 28; 376(1):178-87. PubMed ID: 27037061 [Abstract] [Full Text] [Related]
11. MicroRNA-296 functions as a tumor suppressor in breast cancer by targeting FGFR1 and regulating the Wnt/β-catenin signaling pathway. Sun WM, Tao W, Li JC, Zhu DM, Miao Y. Eur Rev Med Pharmacol Sci; 2019 Dec 28; 23(23):10422-10432. PubMed ID: 31841196 [Abstract] [Full Text] [Related]
12. miR-516a-3p inhibits breast cancer cell growth and EMT by blocking the Pygo2/Wnt signalling pathway. Chi Y, Wang F, Zhang T, Xu H, Zhang Y, Shan Z, Wu S, Fan Q, Sun Y. J Cell Mol Med; 2019 Sep 28; 23(9):6295-6307. PubMed ID: 31273950 [Abstract] [Full Text] [Related]
13. miR-590-3p promotes colon cancer cell proliferation via Wnt/β-catenin signaling pathway by inhibiting WIF1 and DKK1. Feng ZY, Xu XH, Cen DZ, Luo CY, Wu SB. Eur Rev Med Pharmacol Sci; 2017 Nov 28; 21(21):4844-4852. PubMed ID: 29164578 [Abstract] [Full Text] [Related]
14. microRNA-377-3p inhibits osteosarcoma progression by targeting CUL1 and regulating Wnt/β-catenin signaling pathway. Liang K, Liao L, Liu Q, Ouyang Q, Jia L, Wu G. Clin Transl Oncol; 2021 Nov 28; 23(11):2350-2357. PubMed ID: 34133001 [Abstract] [Full Text] [Related]
15. Upregulation of DKK3 by miR-483-3p plays an important role in the chemoprevention of colorectal cancer mediated by black raspberry anthocyanins. Guo J, Yang Z, Zhou H, Yue J, Mu T, Zhang Q, Bi X. Mol Carcinog; 2020 Feb 28; 59(2):168-178. PubMed ID: 31763724 [Abstract] [Full Text] [Related]
16. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway. Kong LY, Xue M, Zhang QC, Su CF. Oncotarget; 2017 Feb 28; 8(9):15507-15519. PubMed ID: 28099945 [Abstract] [Full Text] [Related]
17. MicroRNA-328-3p inhibits the tumorigenesis of bladder cancer through targeting ITGA5 and inactivating PI3K/AKT pathway. Yan T, Ye XX. Eur Rev Med Pharmacol Sci; 2019 Jun 28; 23(12):5139-5148. PubMed ID: 31298367 [Abstract] [Full Text] [Related]
18. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4. Fu W, Tao T, Qi M, Wang L, Hu J, Li X, Xing N, Du R, Han B. Prostate; 2016 Dec 28; 76(16):1560-1570. PubMed ID: 27527117 [Abstract] [Full Text] [Related]
19. MicroRNA-22 targets FMNL2 to inhibit melanoma progression via the regulation of the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition. Shi L, Huo JW, Chen SS, Xue JX, Gao WY, Li XY, Song YH, Xu HT, Zhu XW, Chen K. Eur Rev Med Pharmacol Sci; 2019 Jun 28; 23(12):5332-5342. PubMed ID: 31298385 [Abstract] [Full Text] [Related]
20. Identification of miR-1-3p, miR-143-3p and miR-145-5p association with bone metastasis of Gleason 3+4 prostate cancer and involvement of LASP1 regulation. Guo H, Zhao J, Li X, Sun F, Qin Y, Yang X, Xiong X, Yin Q, Wang X, Gao L, Jiao M, Hu J, Han B. Mol Cell Probes; 2023 Apr 28; 68():101901. PubMed ID: 36791996 [Abstract] [Full Text] [Related] Page: [Next] [New Search]